Neurogene Inc (NGNE)

R&D Expense Growth

1.26%

Quarterly · Period ending:

NGNE logo

NGNE R&D Expense Growth

Latest reported1.26%
NGNE Quarterly R&D Growth (QoQ) (0.00% → 1.26%)
High-resolution chart · PNG

NGNE r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Neurogene Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
1.2644%
21.8567%
19.7088%
-10.9728%
9.0428%
15.7229%
-5.7599%
3.4362%
16.2691%
11.1376%
4.9802%
12.4503%
0.3695%
2.8197%
-7.6035%
-1.2048%
2.383%
9.6414%
-1.3743%
0.7329%
1.2053%
24.6565%
25.2735%
28.3502%
-11.9134%
12.4795%
244.2254%
28,300%
25%
-99.7283%
-47.6715%
-84.3687%
71.26%
-9.0925%
36.6958%
-19.2745%
81.3225%
-28.9597%
32.5725%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.